TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GMED

Globus Medical

Healthcare · Medical Devices

75.60$ +1.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GMED
Line item 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– – 82.1% 78.6% 80.5% 73.6% 66.8% 65.3% 55.4% 57.5% 48.5% 44.9% 48.9% 44.2% 47.4% 37.7% 41.5% 40.1%
– – 41.9% 43.3% 47.5% 15.9% 11.7% 7.2% 7.2% 11.0% 10.7% 12.8% 14.3% 9.9% 7.2% 9.2% 14.9% 9.9%
– – 41.9% 43.3% 47.5% 42.2% 32.5% 33.7% 31.3% 34.7% 26.1% 20.3% 25.4% 22.7% 21.5% 10.2% 16.9% 10.5%
– – 18.2% 15.2% 13.1% 11.5% 11.5% 10.4% 10.3% 11.8% 11.1% 10.6% 8.8% 8.5% 10.5% 9.9% 11.0% 14.0%
– – 15.3% 14.4% 13.9% 12.4% 12.9% 12.6% 12.1% 10.1% 10.1% 12.8% 13.6% 12.1% 14.4% 16.7% 12.6% 14.3%
– – 17.2% 15.9% 13.7% 11.3% 9.9% 13.8% 13.4% 13.3% 13.2% 13.2% 12.9% 11.3% 11.7% – – –
– – – 3.0% 3.4% 3.2% 7.6% 11.0% 11.4% 11.5% 9.5% 8.4% 9.3% 9.2% 9.5% 28.2% 27.3% 27.1%
– – – 2.3% 2.1% 5.2% 4.9% 4.0% 6.7% 7.3% 6.7% 5.1% 5.2% 3.5% 3.1% 18.2% 15.1% 14.1%
– – 14.4% 14.2% 13.6% 16.6% 16.8% 14.2% 10.3% 10.3% 8.9% 8.5% 10.3% 11.0% 11.1% 21.4% 20.5% 13.8%
– – 11.9% 8.9% 8.8% 12.0% 12.7% 9.9% 8.6% 8.6% 7.4% 7.3% 7.2% 7.2% 7.7% 7.7% 16.3% 9.4%
– – 2.0% – – – – – – – 0.3% 4.9% 5.3% 4.8% 0.1% 0.2% 8.6% 0.3%
– – 2.7% 2.0% 2.8% 2.2% 3.0% 1.9% 1.9% 2.3% 2.0% 1.6% 1.1% 1.1% 1.7% 1.1% 1.4% 1.9%
– – – – 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% – – – – – 8.2% – –
– – 85.6% 85.8% 86.4% 83.4% 83.2% 85.8% 89.7% 89.7% 91.1% 91.5% 89.7% 89.0% 88.9% 78.6% 79.5% 86.2%
– – 47.3% 53.7% 56.1% 56.4% 58.5% 62.9% 67.8% 68.3% 68.6% 68.4% 62.2% 61.0% 59.7% 22.4% 22.0% 26.2%
– – 28.3% 22.9% 20.6% 16.6% 13.6% 11.5% 10.4% 9.1% 7.8% 6.7% 6.0% 5.3% 4.9% 2.3% 2.6% 2.6%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?